论文部分内容阅读
在晋、秦、豫三省交汇之处,九曲黄河突然从这里掉头向东奔流而下。亚宝药业集团在晋南这片沃土上茁壮成长,不断书写着一个又一个传奇。不断创新管理模式十几年前,亚宝药业集团的前身只是一个名不见经传的县属药厂,年销售收入只有2.1亿元。如今,经历过改制阵痛迎来跨越式发展的亚宝药业集团已经拥有18个分(子)公司,山西、四川、北京等地均有他们的药厂。集团总资产近30亿元,年销售收入近20亿元,年利税则
In Jin, Qin, Yu intersection of the three provinces, nine of the Yellow River suddenly turn around from here east down. Yaobao Pharmaceutical Group thrives on fertile soil in southern Shanxi, writing one legend after another. Innovative management model Ten years ago, the predecessor of Ya Bao Pharmaceutical Group was a little-known county pharmaceutical factory with annual sales revenue of only 210 million yuan. Today, Yaobao Pharmaceutical Group, which has experienced the leapfrogged transformation through its restructuring, already has 18 sub-companies and their pharmaceutical companies are located in Shanxi, Sichuan and Beijing. Group total assets of nearly 3 billion yuan, annual sales income of nearly 2 billion yuan, annual profits tax